Pr Laurent Greillier

Spécialité

Onco-pneumologue, expert poumon

Titre

Chef de département

Hôpital

AP-HM Hôpital Nord (Marseille)

Derniers articles

• Budigalimab: a viable option for patients with advanced solid tumors. (3 août 2026)
• Development of an externally controlled trial from a single-arm study to assess first-line immunochemotherapy in advanced large cell neuroendocrine lung carcinomas: a study protocol from the FIRST-NEC GFPC 01-2022 trial. (29 juil. 2026)
• First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors. (19 juin 2026)
• First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. (29 mai 2026)
• Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors. (22 avr. 2026)